American Healthcare REIT (NYSE:AHR - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.32 by ($0.35), Zacks reports. The business had revenue of $523.81 million for the quarter, compared to the consensus estimate of $474.26 million. American Healthcare REIT had a negative return on equity of 1.96% and a negative net margin of 1.84%. The company's revenue was up 12.8% compared to the same quarter last year. American Healthcare REIT updated its FY24 guidance to $1.40-1.43 EPS and its FY 2024 guidance to 1.400-1.430 EPS.
American Healthcare REIT Price Performance
Shares of AHR stock traded down $0.55 during trading hours on Thursday, hitting $26.25. 1,900,659 shares of the company's stock were exchanged, compared to its average volume of 1,456,949. American Healthcare REIT has a 12-month low of $12.63 and a 12-month high of $27.77. The company has a market capitalization of $3.46 billion and a PE ratio of -54.63. The business's 50 day simple moving average is $25.16 and its 200-day simple moving average is $19.21. The company has a current ratio of 0.29, a quick ratio of 0.29 and a debt-to-equity ratio of 0.60.
American Healthcare REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, September 20th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 3.81%. The ex-dividend date was Friday, September 20th. American Healthcare REIT's payout ratio is currently -208.33%.
Analyst Ratings Changes
A number of analysts recently issued reports on the company. Truist Financial increased their price objective on American Healthcare REIT from $22.00 to $27.00 and gave the stock a "buy" rating in a report on Friday, September 20th. Colliers Securities raised shares of American Healthcare REIT from a "hold" rating to a "moderate buy" rating in a report on Sunday, October 13th. KeyCorp boosted their price objective on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, September 16th. Bank of America raised their price target on shares of American Healthcare REIT from $27.00 to $31.00 and gave the company a "buy" rating in a report on Tuesday, September 24th. Finally, JMP Securities upped their price target on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a "market outperform" rating in a report on Friday, September 20th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $23.00.
Read Our Latest Stock Analysis on American Healthcare REIT
American Healthcare REIT Company Profile
(
Get Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Further Reading
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.